Parkwood LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Parkwood LLC’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-76,599	Closed	-$3.52M	–	552
2016 Q3	$3.52M	Buy	76,599 +15,293	+25%	+$798K	0.52%	52
2016 Q2	$3.08M	Buy	61,306 +23,115	+61%	+$1.23M	0.51%	54
2016 Q1	$2.04M	Sell	38,191 -14,076	-27%	-$826K	0.35%	67
2015 Q4	$3.43M	Buy	+52,267	New	+$3.23M	0.54%	42
2015 Q3	–	Sell	-8,339	Closed	-$493K	–	551
2015 Q2	$493K	Buy	8,339 +38	+0.5%	+$2.34K	0.07%	192
2015 Q1	$517K	Sell	8,301 -842	-9%	-$49K	0.06%	210
2014 Q4	$526K	Buy	+9,143	New	+$509K	0.07%	179

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Parkwood LLC's TEVA Position: Q4 2016 in Review

Parkwood LLC sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 76,599 shares — an estimated $3.52M sold.

Parkwood LLC first reported a position in TEVA in Q4 2014 and held it in 7 quarters. The position peaked at $3.52M in Q3 2016. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Parkwood LLC reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Parkwood LLC sold 76,599 Teva Pharmaceuticals shares in Q4 2016, an estimated $3.52M.
Parkwood LLC first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 7 quarters.
Parkwood LLC's Teva Pharmaceuticals position peaked at $3.52M in Q3 2016.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Parkwood LLC's 13F filing for Q4 2016, filed 27 Jan 2017.